Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: The possible role of insulin-like growth factor-binding protein-3 proteolysis

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 7, 1998, Pages 2445-2449

  Skjærbæk, Christian ^a,b   Frystyk, Jan ^a   Ørskov, Hans ^a   Kissmeyer Nielsen, Peter ^b   Jensen, Martin Bach ^b   Laurberg, Søren ^b   Møller, Niels ^a   Flyvbjerg, Allan ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ABDOMINAL SURGERY; ADULT; ARTICLE; BINDING AFFINITY; BIOAVAILABILITY; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; FLUID BALANCE; HUMAN; ILEOANAL ANASTOMOSIS; IMMUNOASSAY; MALE; MUSCLE STRENGTH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; SUBCUTANEOUS DRUG ADMINISTRATION; ULTRAFILTRATION;

ADULT; ANALYSIS OF VARIANCE; COLITIS, ULCERATIVE; DOUBLE-BLIND METHOD; ENDOPEPTIDASES; FEMALE; HUMANS; HYDROLYSIS; IMMUNORADIOMETRIC ASSAY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PROCTOCOLECTOMY, RESTORATIVE; SURGICAL PROCEDURES, ELECTIVE;

EID: 0031759902     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.7.2445     Document Type: Article

References (30)

1. Baxter RC. 1988 Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab. 67:265-272.
2. Frystyk J, Skjærbæk C, Dinesen B, Ørskov H. 1994 Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 348:185-191.
3. Timmins AC, Cotteril AW, Cwyfan Hughes SC, et al. 1996 Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. Crit Care Med. 24:1460-1466.
4. Cwyfan Hughes SC, Cotterill AM, Molloy AR, et al. 1992 The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. J Endocrinol. 135:135-145.
5. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M. 1990 Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J Clin Endocrinol Metab. 71:797-805.
6. Lee CY, Rechler MM. 1996 Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I. Endocrinology. 137:2051-2058.
7. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation, and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab. 71:806-816.
8. Suikkari AM, Baxter RC. 1991 Insulin-like growth factor (IGF) binding protein-. 3 in pregnancy serum binds native IGF-I but not iodo-IGF-I. J Clin Endocrinol Metab. 73:1377-1379.
9. Suikkari AM, Baxter RC. 1992 Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum. J Clin Endocrinol Metab. 74:177-183.
10. Blat C, Villaudy J, Binoux M. 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest. 93:2286-2290.
11. Frystyk J, Dinesen B, Ørskov H. 1995 Non-competitive time-resolved immunofluorometric assay for determination of human insulin-like growth factor I and II. Growth Regul. 5:169-176.
12. Hossenlopp P, Seurin D, Segovia Quinson B, Hardouin S, Binoux M. 1986 Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem. 154:138-143.
13. Lamson G, Giudice LC, Rosenfeld RG. 1991 A simple assay for proteolysis of IGFBP-3. J Clin Endocrinol Metab. 72:1391-1393.
14. Ward HC, Halliday D, Sim AJ. 1987 Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg. 206:56-61.
15. Goeters C, Mertes N, Tacke J, et al. 1995 Repeated administration of recombinant human insulin-like growth factor-I in patients after gastric surgery. Effect on metabolic and hormonal patterns. Ann Surg. 222:646-653.
16. Cotterill AM, Mendel P, Holly JM, et al. 1996 The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery. Clin Endocrinol Oxf. 44:91-101.
17. Cox GN, McDermott MJ, Merkel E, et al. 1994 Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology. 135:1913-1920.
18. Lewitt MS, Denyer GS, Cooney GJ, Baxter RC. 1991 Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology. 129:2254-2256.
19. Rajkumar K, Barron D, Lewitt MS, Murphy LJ. 1995 Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology. 136:4029-4034.
20. Mjaaland M, Unneberg K, Bjoro T, Revhaug A. 1993 Growth hormone treatment after abdominal surgery decreased carbohydrate oxidation and increased fat oxidation in patients with total parenteral nutrition. Metabolism. 42:185-190.
21. Tacke J, Bolder U, Lohlein D. 1994 Improved cumulated nitrogen balance after administration of recombinant human growth hormone in patients undergoing gastrointestinal surgery, Infusionsther Transfusionsmed. 21:24-29.
22. Wong WK, Soo KC, Nambiar R, Tan YS, Yo SL, Tan IK. 1995 The effect of recombinant growth hormone on nitrogen balance in malnourished patients after major abdominal surgery. Aust NZ J Surg. 65:109-113.
23. Miell JP, Taylor AM, Jones J, et al. 1992 Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery. Clin Endocrinol (Oxf). 37:542-551.
24. Davenport ML, Isley WL, Pucilowska JB, et al. 1992 Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab. 75:590-595.
25. Skjærbæk C, Frystyk J, Møller J, Christiansen JS, Ørskov H. 1996 Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults. Eur J Endocrinol. 135:672-677.
26. Frystyk J, Vestbo E, Skjærbæk C, Mogensen CE, Ørskov H. 1995 Free insulin-like growth factors in human obesity. Metabolism. 44(Suppl 4):37-44.
27. Skjærbæk C, Vahl N, Frystyk J, et al. 1997 Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement. Eur J Endocrinol. 137:132-137.
28. Guler HP, Zapf J, Schmid C, Froesch ER. 1989 Insulin-like growth factors I, and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh). 121:753-758.
29. Wilton P, Sietnieks A, Gunnarsson R, Berger L, Grahnen A. 1991 Pharmacokinetic profile of recombinant human insulin-like growth factor I given subcutaneously in normal subjects. Acta Paediatr Scand. 377(Suppl):111-114.
30. Skjærbæk C, Kaal A, Møller J, et al. 1998 No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis. J Clin Endocrinol Metab. 83:1206-1210.